You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 27, 2024

Details for New Drug Application (NDA): 022180


✉ Email this page to a colleague

« Back to Dashboard


NDA 022180 describes FERAHEME, which is a drug marketed by Covis and is included in one NDA. It is available from one supplier. Additional details are available on the FERAHEME profile page.

The generic ingredient in FERAHEME is ferumoxytol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the ferumoxytol profile page.
Summary for 022180
Tradename:FERAHEME
Applicant:Covis
Ingredient:ferumoxytol
Patents:0
Pharmacology for NDA: 022180
Suppliers and Packaging for NDA: 022180
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180 NDA AMAG Pharmaceuticals, Inc. 59338-775 59338-775-01 1 VIAL, SINGLE-USE in 1 CARTON (59338-775-01) / 17 mL in 1 VIAL, SINGLE-USE
FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180 NDA AMAG Pharmaceuticals, Inc. 59338-775 59338-775-10 10 VIAL, SINGLE-USE in 1 CARTON (59338-775-10) / 17 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrengthEQ 510MG IRON/17ML (EQ 30MG IRON/ML)
Approval Date:Jun 30, 2009TE:ABRLD:Yes

Expired US Patents for NDA 022180

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 ⤷  Sign Up ⤷  Sign Up
Covis FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 ⤷  Sign Up ⤷  Sign Up
Covis FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 ⤷  Sign Up ⤷  Sign Up
Covis FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.